{"id":16981,"date":"2025-06-26T18:36:15","date_gmt":"2025-06-26T18:36:15","guid":{"rendered":"https:\/\/www.europesays.com\/us\/16981\/"},"modified":"2025-06-26T18:36:15","modified_gmt":"2025-06-26T18:36:15","slug":"americans-must-stop-subsidizing-the-price-of-drugs-in-other-countries","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/16981\/","title":{"rendered":"Americans must stop subsidizing the price of drugs in other countries"},"content":{"rendered":"

President Trump is right that Americans often pay too much for prescription drugs, and that other countries aren\u2019t pulling their weight<\/a>. The status quo isn\u2019t merely unfair \u2014 it\u2019s unsustainable.\u202f\u00a0<\/p>\n

But to fix the problem without deterring the massive research investments that spur economic growth, job creation, and health gains, policymakers will need to address the true drivers of high prices here at home, while simultaneously pressing our allies to contribute more abroad.\u00a0\u00a0<\/p>\n

American leaders can start by tackling the bloated middle of the drug supply chain. Middlemen who neither invent nor administer medicines to patients now collect more in rebates, discounts, and fees than the total price of drugs in many other countries. \u202f\u00a0<\/p>\n

STAT+ Exclusive Story<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\"STAT+\"\/<\/p>\n

\t\t\t\t\t
\n\t\t\t\t\t\t\"STAT+\"\/
\n\t\t\t\t\t<\/a><\/p>\n

\t\t\t\tThis article is exclusive to STAT+ subscribers
\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n

Already have an account? Log in<\/a><\/p>\n

\t\t\t\t\t\tIndividual plans<\/p>\n

\t\t\t\t\t\tGroup plans<\/p>\n

\t\t\t\tView All Plans<\/a><\/p>\n

\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n

\t\t\t\t\tSubscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"President Trump is right that Americans often pay too much for prescription drugs, and that other countries aren\u2019t…\n","protected":false},"author":3,"featured_media":16982,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[150,69,16591,16592,210,1060,152,153,154,67,132,68],"class_list":{"0":"post-16981","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-biotechnology","9":"tag-donald-trump","10":"tag-drug-development","11":"tag-drug-pricing","12":"tag-health","13":"tag-medication","14":"tag-pharmaceuticals","15":"tag-policy","16":"tag-stat","17":"tag-united-states","18":"tag-unitedstates","19":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/114751116864908561","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/16981","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=16981"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/16981\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/16982"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=16981"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=16981"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=16981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}